Evidence map›Paper›PMID 34526387›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Trapping or slowing the diffusion of T cell receptors at close contacts initiates T cell signaling.

Kevin Y Chen, Edward Jenkins, Markus Körbel, Aleks Ponjavic, Anna H Lippert, Ana Mafalda Santos, Nicole Ashman, Caitlin O'Brien-Ball, Jemma McBride, David Klenerman and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Energetic Landscape of Catch Bonds in TCR Interfaces.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kevin Y ChenDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.ORCID 0000-0001-5299-8368
Edward JenkinsRadcliffe Department of Medicine and United Kingdom Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom.ORCID 0000-0003-3789-6421
Markus KörbelDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.ORCID 0000-0002-8344-8016
Aleks PonjavicDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
Anna H LippertDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.ORCID 0000-0002-0771-8491
Ana Mafalda SantosRadcliffe Department of Medicine and United Kingdom Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom.
Nicole AshmanRadcliffe Department of Medicine and United Kingdom Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom.ORCID 0000-0002-7860-3085
Caitlin O'Brien-BallRadcliffe Department of Medicine and United Kingdom Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom.ORCID 0000-0002-8635-3047
Jemma McBrideRadcliffe Department of Medicine and United Kingdom Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom.
David KlenermanDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom; simon.davis@imm.ox.ac.uk dk10012@cam.ac.uk.ORCID 0000-0001-7116-6954
Simon J DavisRadcliffe Department of Medicine and United Kingdom Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom; simon.davis@imm.ox.ac.uk dk10012@cam.ac.uk.ORCID 0000-0002-2280-1170
John Radcliffe Hospital · GBUniversity of Cambridge · GBUniversity of Leeds · GB

Funding

Medical Research Council MC_UU_12010/4Wellcome TrustWellcome Trust 207547/Z/17/Z
6 · The paper itself

Abstract

T cell activation is initiated by T cell receptor (TCR) phosphorylation. This requires the local depletion of large receptor-type phosphatases from "close contacts" formed when T cells interact with surfaces presenting agonistic TCR ligands, but exactly how the ligands potentiate signaling is unclear. It has been proposed that TCR ligands could enhance receptor phosphorylation and signaling just by holding TCRs in phosphatase-depleted close contacts, but this has not been directly tested. We devised simple methods to move the TCR in and out of close contacts formed by T cells interacting with supported lipid bilayers (SLBs) and to slow the receptor's diffusion in the contacts, using a series of anti-CD3ε Fab- and ligand-based adducts of the receptor. TCRs engaging a Fab extended with the large extracellular region of CD45 were excluded from contacts and produced no signaling. Conversely, allowing the extended Fab to become tethered to the SLB trapped the TCR in the close contacts, leading to very strong signaling. Importantly, attaching untethered anti-CD3ε Fab or peptide/MHC ligands, each of which were largely inactive in solution but both of which reduced TCR diffusion in close contacts approximately fivefold, also initiated signaling during cell/SLB contact. Our findings indicate that holding TCRs in close contacts or simply slowing their diffusion in phosphatase-depleted regions of the cell surface suffices to initiate signaling, effects we could reproduce in single-particle stochastic simulations. Our study shows that the TCR is preconfigured for signaling in a way that allows it to be triggered by ligands acting simply as receptor "traps."

Indexed as

Cell CommunicationLymphocyte ActivationCell MembraneHumansLigandsLipid BilayersPhosphorylationReceptors, Antigen, T-CellT-LymphocytesLigandsLipid BilayersReceptors, Antigen, T-Cellcomputer simulationdiffusion analysisreceptor triggeringsignalingT cells

Identifiers

PMID34526387
PMCPMC8488633
OpenAlexW3200543836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.